Internal Medicine, Hematology & Oncology · Tampa, FL
NPI
1063733343
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
12902 Usf Magnolia Dr
Tampa, FL, 33612
Phone (813) 745-4673
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
362 services
Medicare patients, 2024
195
Average age 76
Drug cost, 2024
$5.3M
505 prescriptions
Company payments, 2025
$63K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David A Sallman was code 99214 (office e&m - established), 97 times for 81 patients. In total David A Sallman billed 362 services in 15 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 97 | 81 | $73.45 | $7,125 |
| 99215 Office E&M - Established | Facility | 86 | 70 | $112.25 | $9,653 |
| 99205 Office E&M - New | Facility | 56 | 56 | $140.10 | $7,846 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 39 | 34 | $12.97 | $506 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 24 | 20 | $24.72 | $593 |
| 99214 Office E&M - Established | Office | 15 | 14 | $100.59 | $1,509 |
| 99213 Office E&M - Established | Facility | 13 | 13 | $51.99 | $676 |
By year: 2022 $28K for 294 services; 2023 $29K for 286 services; 2024 $31K for 362 services.
Medicare prescription drug claims, 2024
In 2024, the drug David A Sallman prescribed most often to Medicare patients was Venclexta (Venetoclax), with 82 prescriptions and refills. In total David A Sallman wrote 505 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Venclexta Venetoclax | 82 | 82 | 29 | $542K |
| Xospata Gilteritinib Fumarate | 36 | 36 | 11 | $797K |
| Inqovi Decitabine/Cedazuridine | 26 | 28 | 11 | $228K |
| Allopurinol Generic | 26 | 29 | 17 | $124 |
| Idhifa Enasidenib Mesylate | 25 | 25 | Under 11 | $855K |
| Acyclovir Generic | 24 | 36 | 14 | $783 |
| Jakafi Ruxolitinib Phosphate | 23 | 24 | Under 11 | $409K |
| Cyclosporine Modified Cyclosporine, Modified | 17 | 23 | Under 11 | $2,849 |
| Levofloxacin Generic | 16 | 16 | Under 11 | $271 |
| Tibsovo Ivosidenib | 15 | 15 | Under 11 | $489K |
| Onureg Azacitidine | 15 | 15 | Under 11 | $233K |
| Promacta Eltrombopag Olamine | 12 | 12 | Under 11 | $475K |
| Oxycodone Hcl Generic | 12 | 12 | Under 11 | $72.45 |
| Prochlorperazine Maleate Generic | 12 | 12 | 12 | $161 |
| Omeprazole Generic | 11 | 13 | Under 11 | $96.2 |
Brand drugs: 285 claims; generic drugs: - claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David A Sallman $63K ($63K in general payments such as food, travel and fees) from 17 companies. The largest payer was Syndax Pharmaceuticals, Inc. with $32K.
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. SNDX | 23 | $32K |
| Abbvie Inc. ABBV | 16 | $6,688 |
| Astellas Pharma US Inc 4503.T | 4 | $5,454 |
| Janssen Scientific Affairs, LLC JNJ | 3 | $3,801 |
| Janssen Global Services, LLC JNJ | 3 | $3,773 |
| Geron Corporation GERN | 7 | $2,849 |
| Genentech USA, Inc. ROG.SW | 3 | $1,898 |
| Genmab U.S., Inc. GMAB | 2 | $1,570 |
| Agios Pharmaceuticals, Inc. AGIO | 1 | $1,500 |
| Janssen Research & Development, LLC JNJ | 2 | $1,439 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.